1.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 40 and over Sponsor: NCI, Other Protocol IDs: CDR0000068781, U10CA031946, CALGB-79809, NCI-P01-0184, NCT00022087
|
|
2.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N04C7, N04C7, NCT00316914
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0518, 0518, NCT00329797
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0517, RTOG 0517, NCT00365105
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: ID03-0124, NCT00452439
|
|
6.
|
Phase: Phase III Type: Health services research, Natural history/Epidemiology, Prevention Status: Completed Age: 50 to 79 Sponsor: NCI, NHLBI Protocol IDs: 114, NCT00000611
|
|
7.
|
Phase: Phase III Type: Natural history/Epidemiology, Supportive care Status: Completed Age: 45 and over Sponsor: NCI, Other Protocol IDs: MA27B, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, CDR0000483099, NCIC-MA.27B, NCT00354302
|
|
8.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: NU 02U1, NCT00058188
|
|
9.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: RC08CC, NCI-2009-01229, 08-008811, CA163-195, NCT00998738
|
|
10.
|
Phase: Phase III Type: Prevention Status: Closed Age: 55 and over Sponsor: NCI, Other Protocol IDs: CAPS08-15024, NCT01052051
|
|
11.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OXALI_L_03768, U1111-1116-9494, NCT01087658
|
|
12.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N08CB, N08CB, NCT01099449
|
|
13.
|
Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 2005NT018, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, UMN-2005NT018, NCT00321932
|
|
14.
|
Phase: Phase II Type: Natural history/Epidemiology, Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 6346, NCI-2010-00621, UWCC-6346, NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715
|
|
15.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-4472, SEG-343
|